These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 32098284)
1. Recognition of Lipoproteins by Toll-like Receptor 2 and DNA by the AIM2 Inflammasome Is Responsible for Production of Interleukin-1β by Virulent Suilysin-negative Lavagna A; Auger JP; Girardin SE; Gisch N; Segura M; Gottschalk M Pathogens; 2020 Feb; 9(2):. PubMed ID: 32098284 [No Abstract] [Full Text] [Related]
2. Interleukin-1 signaling induced by Streptococcus suis serotype 2 is strain-dependent and contributes to bacterial clearance and inflammation during systemic disease in a mouse model of infection. Lavagna A; Auger JP; Dumesnil A; Roy D; Girardin SE; Gisch N; Segura M; Gottschalk M Vet Res; 2019 Jul; 50(1):52. PubMed ID: 31262357 [TBL] [Abstract][Full Text] [Related]
3. Contribution of Nlrp3 Inflammasome Activation Mediated by Suilysin to Streptococcal Toxic Shock-like Syndrome. Song L; Li X; Xiao Y; Huang Y; Jiang Y; Meng G; Ren Z Front Microbiol; 2020; 11():1788. PubMed ID: 32922370 [No Abstract] [Full Text] [Related]
4. In vitro characterization of granulocyte-colony stimulating factor (G-CSF) production by dendritic cells and macrophages during Streptococcus suis infection. Bleuzé M; Auger JP; Lavagna A; Gisch N; Gottschalk M; Segura M Immunobiology; 2020 Jul; 225(4):151979. PubMed ID: 32747024 [TBL] [Abstract][Full Text] [Related]
5. Type I Interferon Induced by Auger JP; Santinón A; Roy D; Mossman K; Xu J; Segura M; Gottschalk M Front Immunol; 2017; 8():1039. PubMed ID: 28894449 [No Abstract] [Full Text] [Related]
6. Distribution and genetic diversity of suilysin in Streptococcus suis isolated from different diseases of pigs and characterization of the genetic basis of suilysin absence. King SJ; Heath PJ; Luque I; Tarradas C; Dowson CG; Whatmore AM Infect Immun; 2001 Dec; 69(12):7572-82. PubMed ID: 11705935 [TBL] [Abstract][Full Text] [Related]
7. Differential role of MyD88 signaling in Streptococcus suis serotype 2-induced systemic and central nervous system diseases. Auger JP; Benoit-Biancamano MO; Bédard C; Segura M; Gottschalk M Int Immunol; 2019 Oct; 31(11):697-714. PubMed ID: 30944920 [TBL] [Abstract][Full Text] [Related]
8. Role of suilysin in pathogenesis of Streptococcus suis capsular serotype 2. Lun S; Perez-Casal J; Connor W; Willson PJ Microb Pathog; 2003 Jan; 34(1):27-37. PubMed ID: 12620382 [TBL] [Abstract][Full Text] [Related]
9. Amentoflavone Ameliorates Streptococcus suis-Induced Infection Shen X; Niu X; Li G; Deng X; Wang J Appl Environ Microbiol; 2018 Dec; 84(24):. PubMed ID: 30315078 [No Abstract] [Full Text] [Related]
10. Quercetin reduces Streptococcus suis virulence by inhibiting suilysin activity and inflammation. Li G; Shen X; Wei Y; Si X; Deng X; Wang J Int Immunopharmacol; 2019 Apr; 69():71-78. PubMed ID: 30682719 [TBL] [Abstract][Full Text] [Related]
11. Membrane Binding, Cellular Cholesterol Content and Resealing Capacity Contribute to Epithelial Cell Damage Induced by Suilysin of Vötsch D; Willenborg M; Oelemann WMR; Brogden G; Valentin-Weigand P Pathogens; 2019 Dec; 9(1):. PubMed ID: 31905867 [No Abstract] [Full Text] [Related]
12. The genetically modified suilysin, rSLY(P353L), provides a candidate vaccine that suppresses proinflammatory response and reduces fatality following infection with Streptococcus suis. Du H; Huang W; Xie H; Ye C; Jing H; Ren Z; Xu J Vaccine; 2013 Aug; 31(38):4209-15. PubMed ID: 23856333 [TBL] [Abstract][Full Text] [Related]
13. Antigen I/II Participates in the Interactions of Auger JP; Boa AC; Segura M; Gottschalk M Front Cell Infect Microbiol; 2019; 9():124. PubMed ID: 31069179 [No Abstract] [Full Text] [Related]
14. Acquiring high expression of suilysin enable non-epidemic Xu L; Lin L; Lu X; Xiao P; Liu R; Wu M; Jin M; Zhang A Emerg Microbes Infect; 2021 Dec; 10(1):1309-1319. PubMed ID: 33792531 [TBL] [Abstract][Full Text] [Related]
15. Exploring the destructive synergy between IL-33 and Suilysin hemolysis on blood-brain barrier stability. Fu Y; Jie J; Lei L; Liu M; Wang J; Lei L; Liu H Microbiol Spectr; 2024 Aug; 12(8):e0061224. PubMed ID: 38980021 [No Abstract] [Full Text] [Related]
16. Serotype distribution and production of muramidase-released protein, extracellular factor and suilysin by field strains of Streptococcus suis isolated in the United States. Fittipaldi N; Fuller TE; Teel JF; Wilson TL; Wolfram TJ; Lowery DE; Gottschalk M Vet Microbiol; 2009 Nov; 139(3-4):310-7. PubMed ID: 19596529 [TBL] [Abstract][Full Text] [Related]
17. Subcytolytic effects of suilysin on interaction of Streptococcus suis with epithelial cells. Seitz M; Baums CG; Neis C; Benga L; Fulde M; Rohde M; Goethe R; Valentin-Weigand P Vet Microbiol; 2013 Dec; 167(3-4):584-91. PubMed ID: 24095145 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory Effect of Piceatannol on Wang G; Gao Y; Wu X; Gao X; Zhang M; Liu H; Fang T Front Microbiol; 2020; 11():593588. PubMed ID: 33329477 [TBL] [Abstract][Full Text] [Related]
19. Increased production of suilysin contributes to invasive infection of the Streptococcus suis strain 05ZYH33. He Z; Pian Y; Ren Z; Bi L; Yuan Y; Zheng Y; Jiang Y; Wang F Mol Med Rep; 2014 Dec; 10(6):2819-26. PubMed ID: 25241621 [TBL] [Abstract][Full Text] [Related]
20. The contribution of suilysin to the pathogenesis of Streptococcus suis meningitis. Takeuchi D; Akeda Y; Nakayama T; Kerdsin A; Sano Y; Kanda T; Hamada S; Dejsirilert S; Oishi K J Infect Dis; 2014 May; 209(10):1509-19. PubMed ID: 24285845 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]